Finance

Beta
Lists
NRIX:NASDAQ
Nurix Therapeutics Inc
$22.90
+1.96%
(+0.44) 1D
$22.90
0.00% (0.00)
After hours
Closed: Jun 26, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRIX...
Open
$22.20
High
$23.72
Low
$21.78
Mkt. cap
2.37B
Avg. vol.
2.74M
Volume
6.49M
52-wk high
$23.72
52-wk low
$8.20
EPS
-$3.16
Beta
1.86
Shares outstanding
103.41M
No. of employees
317
Open
$22.20
High
$23.72
Low
$21.78
Mkt. cap
2.37B
Avg. vol.
2.74M
Volume
6.49M
52-wk high
$23.72
52-wk low
$8.20
EPS
-$3.16
Beta
1.86
Shares outstanding
103.41M
No. of employees
317
News stories
From sources across the web
About Nurix Therapeutics Inc
CEO-
Employees317
Founded2009
HeadquartersBrisbane, California, United States
SectorBiotechnology
Websitenurixtx.com
Analyst ratings
Based on 12 analysts giving stock ratings to NRIX in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for NRIX in the last 3 months.
Highest
Current $22.90
$45.00 (+96.51%)
Average
$33.00 (+44.10%)
Lowest
$25.00 (+9.17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$34.00
+48.5%
06/15/2026
Roger Song
Jefferies
Buy
Maintained
$45.00
+96.5%
06/15/2026
Gil Blum
Needham
Buy
Maintained
$34.00
+48.5%
06/15/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
-
-
06/11/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$32.00
+39.7%
06/11/2026
Terence Flynn
Morgan Stanley
Buy
Maintained
$36.00
+57.2%
06/08/2026
Jeet Mukherjee
BTIG
Buy
Maintained
$32.00
+39.7%
06/11/2026
Gregory Renza
Truist Financial
Buy
Reiterated
$32.00
+39.7%
06/09/2026
Derek Archila
Wells Fargo
Hold
Downgraded
$25.00
+9.2%
06/09/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
$28.00
+22.3%
05/13/2026
Biren Amin
Piper Sandler
Buy
Maintained
$35.00
+52.8%
05/13/2026
Brian Abrahams
RBC Capital
Buy
Reiterated
$30.00
+31%
04/08/2026
Nevin Varghese
RBC Capital
Buy
Reiterated
$30.00
+31%
04/08/2026
Joseph Catanzaro
Mizuho Securities
Buy
Maintained
$30.00
+31%
01/29/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
44.06M
7.89M
13.58M
6.25M
Cost of goods sold
78.10M
86.12M
83.02M
84.14M
Cost of revenue
78.10M
86.12M
83.02M
84.14M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.28M
13.16M
13.65M
14.61M
Operating expense
14.28M
13.16M
13.65M
14.61M
Total operating expenses
92.38M
99.28M
96.67M
98.75M
Operating income
-48.32M
-91.38M
-83.10M
-92.50M
Other non operating income
-
-
-
-
EBT including unusual items
-42.70M
-86.42M
-78.22M
-87.17M
EBT excluding unusual items
-42.70M
-86.42M
-78.22M
-87.17M
Income tax expense
760.00K
-
-
-
Effective tax rate
-1.78%
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.46M
-86.42M
-78.22M
-87.17M
Net profit margin
-98.66%
-1,094.77%
-576.13%
-1,394.34%
Earnings per share
-0.52
-1.03
-0.82
-0.79
Interest and investment income
5.62M
4.96M
4.87M
5.32M
Interest expense
-
-
-
-
Net interest expenses
5.62M
4.96M
4.87M
5.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.08M
-89.36M
-81.58M
-90.30M
Gain or loss from assets sale
-
-
89.00K
160.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of NRIX
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer